Suspended MDCK cell platform
Vaccine production platform using monoclonal suspended MDCK cells adapted to chemically defined culture media.
Features of the suspended MDCK cell platform: ■ Monoclonal suspended MDCK cells Cells adapted to animal component-free serum-free medium without the use of genetic recombination from ATCC MDCK (NBL-2) CCL-34. ■ 4Cell MDXK CD Medium A chemically defined medium designed for the growth and infection of MDCK cells, free from animal-derived components and proteins. ■ Support Services We provide technical support throughout cell bank testing, safety testing, characterization, upstream and downstream processes, and scale-up.
basic information
Our floating MDCK cell platform is a comprehensive and scalable solution designed specifically for developers and manufacturers of vaccines targeting influenza.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
